Aroa Biosurgery

A New Zealand-based biotechnology company specializing in regenerative medicine

Aroa Biosurgery Emblem

Aroa Biosurgery is a biotechnology company based in New Zealand that focuses on the development and commercialization of regenerative tissue substitutes for medical use. The company is known for its innovative approach to wound care and soft tissue reconstruction, utilizing its proprietary extracellular matrix (ECM) technology.

History

Aroa Biosurgery was founded in 2008 by Dr. Brian Ward, a scientist with a background in biotechnology and medical devices. The company was established with the aim of creating advanced regenerative solutions for complex wounds and soft tissue repair. Over the years, Aroa has expanded its product portfolio and gained recognition in the field of regenerative medicine.

Technology

Aroa Biosurgery's core technology is based on the use of an extracellular matrix derived from ovine (sheep) forestomach. This ECM is rich in structural proteins and bioactive molecules that support tissue regeneration. The company's products are designed to provide a scaffold that facilitates the body's natural healing processes, promoting cell proliferation and tissue integration.

Products

Aroa Biosurgery offers a range of products for different medical applications:

• Endoform® - A wound care product used for the management of acute and chronic wounds. It is designed to provide a natural scaffold for tissue regeneration.
• Myriad™ - A soft tissue reconstruction product used in surgical procedures to support tissue repair and regeneration.
• Symphony® - A product designed for complex wound management, providing a robust scaffold for tissue regeneration in challenging wound environments.

Applications

The products developed by Aroa Biosurgery are used in various medical fields, including:

• Wound care - For the treatment of chronic wounds such as diabetic ulcers, venous ulcers, and pressure ulcers.
• Surgical reconstruction - In procedures requiring soft tissue repair, such as hernia repair and breast reconstruction.
• Burn treatment - To support the healing of burn injuries by providing a scaffold for new tissue growth.

Research and Development

Aroa Biosurgery invests significantly in research and development to advance its ECM technology and expand its product offerings. The company collaborates with leading research institutions and healthcare providers to explore new applications and improve existing products.

Global Presence

While headquartered in New Zealand, Aroa Biosurgery has a global presence, with its products being used in healthcare facilities across North America, Europe, and Asia. The company continues to expand its market reach through strategic partnerships and distribution agreements.

Related pages

• Regenerative medicine
• Biotechnology
• Wound healing
• Tissue engineering